Biocon Biologics

The deal has been cleared under the green channel route

As per the new terms, Serum would make an additional equity investment of $150 million through the conversion of the $150 million…

The annual Asia-Pacific Bioprocessing Excellence Awards organised by IMAPAC, recognise organisations who demonstrate exceptional…

He will lead Biocon Biologics in realising its goal of being a global biosimilars leader

Biocon Biologics will recognise the combined revenue and associated profits from the acquired collaboration biosimilars with…

bUstekinumab and bDenosumab to address market opportunity of approximately $700 million

The 562,000 sq ft facility has been recognised as the first and largest integrated insulin manufacturer in Malaysia by MBR

Hopefully, this case will initiate as deep a clean up and introspection as the 2012 PCC report

A statement from the company claimed that besides its employees, all its consultants, suppliers and partners are also bound by a…

Abevmy, co-developed by the two companies, is a biosimilar to Roche’s Avastin (Bevacizumab), and has been approved by Health…